[go: up one dir, main page]

AR048958A1 - Medicamento en forma de pelicula para administracion por via oral, que contiene estriol - Google Patents

Medicamento en forma de pelicula para administracion por via oral, que contiene estriol

Info

Publication number
AR048958A1
AR048958A1 ARP050101957A ARP050101957A AR048958A1 AR 048958 A1 AR048958 A1 AR 048958A1 AR P050101957 A ARP050101957 A AR P050101957A AR P050101957 A ARP050101957 A AR P050101957A AR 048958 A1 AR048958 A1 AR 048958A1
Authority
AR
Argentina
Prior art keywords
film
medication
estriol
administration via
via oral
Prior art date
Application number
ARP050101957A
Other languages
English (en)
Inventor
Moormann Joachim Dr
Elger Walter Dr
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of AR048958A1 publication Critical patent/AR048958A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente se refiere a medicamentos en forma de película para administracion por vía oral, en particular por vía bucal, indicados para el tratamiento de los trastornos climatéricos, por cuanto los medicamentos contienen como sustancias activas estriol y/o al menos un éster de estriol farmacologicamente aceptable, solo o combinado al menos con un gestogeno.
ARP050101957A 2004-05-14 2005-05-13 Medicamento en forma de pelicula para administracion por via oral, que contiene estriol AR048958A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004023984A DE102004023984A1 (de) 2004-05-14 2004-05-14 Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol

Publications (1)

Publication Number Publication Date
AR048958A1 true AR048958A1 (es) 2006-06-14

Family

ID=34977101

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101957A AR048958A1 (es) 2004-05-14 2005-05-13 Medicamento en forma de pelicula para administracion por via oral, que contiene estriol

Country Status (16)

Country Link
US (1) US20070243217A1 (es)
EP (1) EP1761242A2 (es)
JP (1) JP2007537178A (es)
KR (1) KR20070040753A (es)
CN (1) CN1997349A (es)
AR (1) AR048958A1 (es)
AU (1) AU2005244409A1 (es)
BR (1) BRPI0510855A (es)
CA (1) CA2566325A1 (es)
DE (1) DE102004023984A1 (es)
IL (1) IL179014A0 (es)
MX (1) MXPA06012890A (es)
NO (1) NO20065657L (es)
RU (1) RU2006140649A (es)
TW (1) TW200536547A (es)
WO (1) WO2005110358A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2252261A2 (en) * 2008-02-13 2010-11-24 Bayer Schering Pharma Aktiengesellschaft Drug delivery system with stabilising effect
MX2010008940A (es) * 2008-02-13 2010-10-05 Bayer Schering Pharma Ag Sistemas de administracion de drogas que contienen estradiol.
US20090269403A1 (en) * 2008-04-24 2009-10-29 Shaked Ze Ev Oral contraceptive dosage forms and methods of making such dosage forms
WO2010033832A2 (en) * 2008-09-19 2010-03-25 Evestra, Inc. Estriol formulations
DE102009007771B4 (de) * 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend
KR102044515B1 (ko) * 2019-08-20 2019-11-14 이영환 구강점막 부착력이 우수한 서방형 구강붕해용 필름 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE209919T1 (de) * 1987-09-24 2001-12-15 Jencap Res Ltd Oestrogen und progestin enthaltende verhütungspackungen
DK0630248T3 (da) * 1992-03-21 1999-06-23 Entec Anvendelse af estriol til fremstilling af et transdermalt terapeutisk system til behandling af klimakteriel osteoporosis
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
DE19832169A1 (de) * 1998-07-17 2000-01-27 Jenapharm Gmbh Lokal anwendbare pharmazeutische Präparate zur Prophylaxe und Therapie atrophischer Erscheinungen in der Mundhöhle
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
DE19932603A1 (de) * 1999-07-13 2001-01-25 Gruenenthal Gmbh Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren
RS52149B (sr) * 2000-01-18 2012-08-31 Bayer Schering Pharma Aktiengesellschaft Farmaceutska kombinacija mikronizovanog drospirenona i estrogena za terapiju zamene hormona

Also Published As

Publication number Publication date
NO20065657L (no) 2006-12-07
AU2005244409A1 (en) 2005-11-24
CA2566325A1 (en) 2005-11-24
EP1761242A2 (de) 2007-03-14
IL179014A0 (en) 2007-03-08
US20070243217A1 (en) 2007-10-18
TW200536547A (en) 2005-11-16
DE102004023984A1 (de) 2005-12-08
WO2005110358A2 (de) 2005-11-24
JP2007537178A (ja) 2007-12-20
CN1997349A (zh) 2007-07-11
MXPA06012890A (es) 2007-07-19
BRPI0510855A (pt) 2007-12-26
KR20070040753A (ko) 2007-04-17
RU2006140649A (ru) 2008-05-27
WO2005110358A3 (de) 2007-03-15

Similar Documents

Publication Publication Date Title
AR065809A1 (es) Formulaciones farmaceuticas que contienen un inhibidor sglt2
CO6400186A2 (es) Tabletas de acetato de ulipristal
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
AR061169A1 (es) Formulaciones farmaceuticas de fenilferina y composiciones para su absorcion en el colon
ES2531118T3 (es) Composición farmacéutica que comprende lacosamida y levetiracetamo para uso en el tratamiento de la epilepsia
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
MX2009000730A (es) Liberacion controlada de formulaciones y metodos asociados.
ECSP066346A (es) Forma de administración a prueba de abuso
ECSP066345A (es) Forma de administración a prueba de abuso
CL2008003615A1 (es) Composicion farmaceutica transmucosal oral que comprende fenilefrina, o una sal de ella, que esta en forma de tiras, de capa bioadhesiva, de liquido para pulverizar, de pastilla , de gel, de capsulas o de tableta; dispositivo portador.
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
PE20060002A1 (es) Combinaciones antineoplasicas de cci-779 y rituximab
SV2008003018A (es) Formulaciones medicamentosas que contienen fluoroquinolonas
AR042543A1 (es) Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroides
EP1781277A4 (en) COMBINATION PREPARATION
PE20120956A1 (es) Composicion farmaceutica que contiene buprenorfina y nalmefeno
AR048958A1 (es) Medicamento en forma de pelicula para administracion por via oral, que contiene estriol
GT200800235A (es) Formulacion de medicamento liquida
CO6260073A2 (es) Composicion farmaceutica que comprende flibanserina o una base libre del mismo o sus sales de adicion farmacologicamente aceptables
BRPI0509067A (pt) formulações de matriz oral que compreendem licarbazepina
CR8059A (es) Composicion farmaceutica en forma de hidrogel para administracion transdermica de sustancias activas
BRPI0509014A (pt) comprimidos desintegráveis que compreendem licarbazepina
AR044831A1 (es) Forma de administracion inyectable de la flupirtina
UY30065A1 (es) Composiciones farmacéuticas para la erradicación de helicobacter pylori
CL2008003584A1 (es) Uso de la 10-[(3r)-1-azabiciclo]oct-3-ilmetil]-10-h-fenotiazina, o una de sus sales farmaceuticamente aceptables para la preparación de un medicamento util para prevenir o tratar la bronconeumopatia obstructiva.

Legal Events

Date Code Title Description
FB Suspension of granting procedure